Facial pain: trigeminal neuralgia

Area of Science:

• Neurology
• Pain Management
• Neurosurgery

Background:

• Atypical facial pain is a broad term for facial pain syndromes, often linked to psychiatric conditions and lacking clear neurophysiological explanation.
• This pain is typically constant, stress-aggravated, and resistant to conventional treatments, with surgery being contraindicated.

Purpose of the Study:

• To differentiate atypical facial pain from trigeminal neuralgia.
• To outline treatment strategies for trigeminal neuralgia, including medical and surgical options.

Main Methods:

• The abstract differentiates between atypical facial pain and trigeminal neuralgia based on pain characteristics and response to treatment.
• It discusses the potential pathophysiology of trigeminal neuralgia, involving peripheral disturbance and central disinhibition.
• Treatment options for trigeminal neuralgia, including anti-epileptic drugs and various surgical interventions, are reviewed.

Main Results:

• Trigeminal neuralgia presents as paroxysmal pain triggered by specific factors, with pain-free intervals.
• Anti-epileptic drugs (e.g., Tegretol) are effective initially for most trigeminal neuralgia patients.
• Surgery becomes a viable option when medical treatment fails or for specific organic causes like tumors.

Conclusions:

• Trigeminal neuralgia has distinct characteristics and a better treatment prognosis than atypical facial pain.
• Effective management of trigeminal neuralgia involves a stepwise approach, often progressing from medication to surgical intervention.
• Surgical options for trigeminal neuralgia include peripheral procedures, microvascular decompression, and trigeminal tractotomy, chosen based on the underlying cause and patient factors.